Haas Kevin Richard bought MYGN
February 2, 2026 · Form 4 insider transaction
Haas Kevin Richard bought 23,697 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
23,697
Price
$0.00
Total value
N/A
InsiderHaas Kevin Richard
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 3, 2026
Shares owned after202,332
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.